Iron Mobilization From Transferrin And Non-Transferrin-Bound-Iron by Deferiprone. Implications in the Treatment of Thalassemia, Anemia of Chronic Disease, Cancer and Other Conditions-Reference-Cited by-同舟云学术

Iron Mobilization From Transferrin And Non-Transferrin-Bound-Iron by Deferiprone. Implications in the Treatment of Thalassemia, Anemia of Chronic Disease, Cancer and Other Conditions

Published:2006-01 Issue:2 Volume:30 Page:183-200
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Kontoghiorghes George J.

Publisher

Informa UK Limited

Subject

Biochemistry, medical,Clinical Biochemistry,Genetics(clinical),Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03630260600642450

Reference32 articles.

1. Benefits and Risks of Deferiprone in Iron Overload in Thalassaemia and Other Conditions

2. Structure/Function Overview of Proteins Involved in Iron Storage and Transport

3. The synergistic binding of anions and Fe3+ by transferrin. Implications for the interlocking sites hypothesis.

4. The formation of Fe3+-transferrin-CO3(2-) via the binding and oxidation of Fe2+.

5. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues;International Journal of Molecular Sciences;2024-05-29

2. Targeting ferroptosis opens new avenues for the development of novel therapeutics;Signal Transduction and Targeted Therapy;2023-09-21

3. Thalassemia and malignancies: Updates from the literature;Annals of the New York Academy of Sciences;2023-09-07

4. Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications;International Journal of Molecular Sciences;2023-08-18

5. The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases;Pharmaceuticals;2023-07-18